Strategy and clarity for emerging biotech
Allometric works with biotech and pharmaceutical startups, academic spinouts, and research-driven organizations navigating complex clinical and regulatory pathways.
SERVICES
Translating discovery into real-world therapies
Strategic Clinical Development
Advancing a novel therapy from discovery to first-in-human studies requires both scientific rigor and a cohesive long-range plan. As a strategic advisor, I help emerging biotech and pharma teams translate early discoveries into structured development strategies that align preclinical, CMC, and clinical plans, anticipate regulatory expectations, and support investor confidence.
Cross-functional Program Leadership
Successful biotech and pharma programs depend as much on people and processes as on scientific insight. Across my roles as Chief Science Officer, regulatory and quality leader, and board director, I’ve built organizations from the ground up, managed international teams, and overseen everything from GCP-compliant trial infrastructure to GMP manufacturing and nonclinical operations.
Communication and Stakeholder engagement
Clear communication unites teams, earns investor trust, and drives successful regulatory interactions. With experience presenting to boards, managing investor-facing narratives, reviewing technical documents, and serving as a university instructor, I bring a structured yet empathetic communication style that helps stakeholders understand not just what will happen, but why it matters.